Hepatic Niemann-Pick C1-Like 1 exacerbates non-alcoholic fatty liver disease by re-absorbing specific biliary oxysterols-Reference-Cited by-同舟云学术

Hepatic Niemann-Pick C1-Like 1 exacerbates non-alcoholic fatty liver disease by re-absorbing specific biliary oxysterols

Published:2022-12 Issue: Volume:156 Page:113877
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Yamanashi Yoshihide,Takada Tappei,Tanaka Yusuke,Ogata Yutaka,Toyoda Yu,Ito Sayo M.,Kitani Maiko,Oshida Natsumi,Okada Kosuke,Shoda Junichi,Suzuki Hiroshi

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference53 articles.

1. Disease progression: divergent paths;DeWeerdt;Nature,2017

2. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms;Wree;Nat. Rev. Gastroenterol. Hepatol.,2013

3. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption;Altmann;Science,2004

4. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1);Garcia-Calvo;Proc. Natl. Acad. Sci. USA,2005

5. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe;Temel;J. Clin. Investig.,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can NPC1L1 inhibitors reduce the risk of biliary tract cancer? Evidence from a mendelian randomization study;Digestive and Liver Disease;2024-09

2. Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions;Pharmaceuticals;2024-08-15

3. Downregulation of CYP7B1 caused by lipotoxicity associates with the progression of non-alcoholic steatohepatitis;2023-05-10

4. Could Lowering Phytosterol Absorption as Part of Lipid-Lowering Therapy Have a Beneficial Effect on Residual Risk?;Metabolites;2023-01-18